Clinical Trial Update: Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating the combination of simvastatin with panitumumab for advanced or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN